(Q43505905)

24 November 2017

title

Reduction of liver Fas expression by an antisense oligonucleotide protects mice from fulminant hepatitis (English)

1 reference

24 November 2017

Zhang H

1

1 reference

24 November 2017

Cook J

2

1 reference

24 November 2017

Nickel J

3

1 reference

24 November 2017

Yu R

4

1 reference

24 November 2017

Stecker K

5

1 reference

24 November 2017

Myers K

6

1 reference

24 November 2017

Dean NM

7

1 reference

24 November 2017

publication date

1 August 2000

1 reference

24 November 2017

1 reference

24 November 2017

volume

18

1 reference

24 November 2017

issue

8

1 reference

24 November 2017

page(s)

862-867

1 reference

24 November 2017

1 reference

CD95-induced apoptosis in human liver disease

21 January 2018

1 reference

Essential roles of the Fas-Fas ligand pathway in the development of pulmonary fibrosis

21 January 2018

1 reference

Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin.

21 January 2018

1 reference

Fas and Fas ligand expression in the salivary glands of patients with primary Sjögren's syndrome.

21 January 2018

1 reference

Fas LIGAND, TUMOR NECROSIS FACTOR-?? EXPRESSION, AND APOPTOSIS DURING ALLOGRAFT REJECTION AND TOLERANCE

21 January 2018

1 reference

Involvement of the CD95 (APO-1/Fas) receptor and ligand system in Helicobacter pylori-induced gastric epithelial apoptosis

21 January 2018

1 reference

Pharmacology of antisense oligonucleotide inhibitors of protein expression

21 January 2018

1 reference

Induction of endogenous Bcl-xS through the control of Bcl-x pre-mRNA splicing by antisense oligonucleotides

21 January 2018

1 reference

Antisense oligonucleotides directed against the viral RNA polymerase gene enhance survival of mice infected with influenza A.

21 January 2018

1 reference

In vivo targeting of inducible NO synthase with oligodeoxynucleotides protects rat kidney against ischemia.

21 January 2018

1 reference

Oligonucleotide-based inhibition of embryonic gene expression.

21 January 2018

1 reference

Molecular mechanisms of antisense drugs: RNase H.

21 January 2018

1 reference

Characterization of a potent and specific class of antisense oligonucleotide inhibitor of human protein kinase C-alpha expression

21 January 2018

1 reference

Lethal effect of the anti-Fas antibody in mice

21 January 2018

1 reference

Raised plasma soluble Fas and Fas-ligand in alcoholic liver disease

21 January 2018

1 reference

A T cell-dependent experimental liver injury in mice inducible by concanavalin A

21 January 2018

1 reference

Hepatic Fas antigen expression before and after interferon therapy in patients with chronic hepatitis C.

21 January 2018

1 reference

Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas.

21 January 2018

1 reference

CD40 activation induces apoptosis in cultured human hepatocytes via induction of cell surface fas ligand expression and amplifies fas-mediated hepatocyte death during allograft rejection

21 January 2018

1 reference

2'-O-(2-Methoxy)ethyl-modified anti-intercellular adhesion molecule 1 (ICAM-1) oligonucleotides selectively increase the ICAM-1 mRNA level and inhibit formation of the ICAM-1 translation initiation complex in human umbilical vein endothelial cells.

21 January 2018

1 reference

Quantitation of phosphorothioate oligonucleotides in human plasma

21 January 2018

1 reference

Essential roles of the Fas ligand in the development of hepatitis

21 January 2018

1 reference

7 January 2021

CD95 (APO-1/Fas)-mediated apoptosis in colon epithelial cells: a possible role in ulcerative colitis

1 reference

7 January 2021

Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis

1 reference

7 January 2021

Therapeutic effect of an anti-Fas ligand mAb on lethal graft-versus-host disease

1 reference

7 January 2021

Histopathology of acetaminophen-induced liver changes: role of interleukin 1 alpha and tumor necrosis factor alpha

1 reference

7 January 2021

Fas antigen expression in liver tissues of patients with chronic hepatitis B

1 reference

7 January 2021

In situ investigation of Fas/FasL expression in chronic hepatitis B infection and related liver diseases

1 reference

7 January 2021

Hepatic failure and liver cell damage in acute Wilson's disease involve CD95 (APO-1/Fas) mediated apoptosis

1 reference

7 January 2021

Contribution of Fas ligand to T cell-mediated hepatic injury in mice

1 reference

7 January 2021

Antisense oligonucleotide inhibition of hepatitis C virus gene expression in transformed hepatocytes

1 reference

7 January 2021

Identifiers

DOI

10.1038/78475

1 reference

Dimensions Publication ID

24 November 2017

1012419864

0 references

1 reference